Lynx1 Capital Management’s Neuphoria Therapeutics Inc. Common Stock NEUP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Hold |
45,806
| – | – | 0.09% | 13 |
|
|
2025
Q1 | $264K | Hold |
45,806
| – | – | 0.09% | 13 |
|
|
2024
Q4 | $157K | Hold |
45,806
| – | – | 0.06% | 17 |
|
|
2024
Q3 | $241K | Sell |
45,806
-4,167
| -8% | -$22K | 0.09% | 14 |
|
|
2024
Q2 | $460K | Sell |
49,973
-17,899
| -26% | -$165K | 0.17% | 12 |
|
|
2024
Q1 | $839K | Sell |
67,872
-820
| -1% | -$10.1K | 0.22% | 15 |
|
|
2023
Q4 | $1.22M | Buy |
68,692
+733
| +1% | +$13K | 0.48% | 13 |
|
|
2023
Q3 | $2.2M | Buy |
+67,959
| New | +$2.2M | 1.46% | 12 |
|